NewsDesk @bactiman63 Pfizer Inc. and Valneva SE announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to investigate the efficacy,...

NewsDesk @bactiman63 NSW Health reports two cases of meningococcal disease in people who attended the 2022 Splendour in the Grass festival at the North Byron Parklands in Yelgun. One of these cases was...

NewsDesk @bactiman63 ARS Reunion reports four cases of diphtheria on the island since the beginning of the year– a teenager and three adults over the age of 55 who have not travelled. Typically,...

NewsDesk @bactiman63 The Minister of Health and Sports of Bolivia, Jeyson Auza posted on Facebook Thursday: After doing the pertinent studies we have confirmed a case of Rubella in Trinidad, Beni. Before...

NewsDesk @bactiman63 The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the indication of the smallpox vaccine Imvanex to include protecting adults...

NewsDesk @bactiman63 Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and when it might...

NewsDesk @bactiman63 Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in a Phase 1 trial of...

NewsDesk @bactiman63 According to the Yemeni Ministry of Public Health and Population (MOPHP), during the past 5 months of this year, the number of measles infected people in areas controlled by the Yemeni...

NewsDesk @bactiman63 Bavarian Nordic A/S announced Thursday that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases...

NewsDesk @bactiman63 The International Vaccine Institute (IVI) and SK bioscience announced this week that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for...